News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 410
- Sources here
- 22
- Companies here
- 11
Search results
Stored financial headlines
Active search
410 matching headlines
Ticker or company: SPIRMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
AQR Capital discloses 6.44% Inspire Medical Systems (INSP) ownership on Schedule 13G
AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a beneficial ownership of 6.44% in Inspire Medical Systems, Inc. (INSP) through a Schedule 13G filing. The AQR entities collectively own 1,856,800 shares, with shared voting power over 1,783,224 shares …
INSP
main company
Sharemaestro market context
Price above Trend Line
52 weeks -40.5%
Inspired Entertainment: Playtech SaaS Rollout Begins As Interactive Revenue Grows 15% And Digital Expansion Accelerates
Inspired Entertainment has initiated the rollout of its Virtual Sports content via a SaaS agreement with Playtech, starting with Malta Lottery, as its Interactive business expands and shifts towards higher-margin digital operations. In Q2, Interactive revenue rose 15% year-over-year to $15.7 million, with Adjusted …
INSE
main company
Sharemaestro market context
Price below Trend Line
52 weeks -28.3%
Agencia Comercial Spirits Signs US$10 Million, Five-Year Networking Deal to Advance Indonesia AI Infrastructure
Agencia Comercial Spirits Ltd. has signed a five-year, US$10 million networking integration services agreement to support its AI computing infrastructure deployment in Indonesia. This deal provides network access and ongoing maintenance for the platform, scaling Agencia’s AI business alongside its whisky operations. However, management …
AGCC
main company
Sharemaestro market context
Trend signal ended
43 weeks +225.9%
Spire Inc. (NYSE:SR) Given Consensus Rating of "Moderate Buy" by Analysts
Analysts have given Spire Inc. (NYSE:SR) a consensus "Moderate Buy" rating, with an average 12-month price target of $94.50. The company recently reported quarterly revenue of $420.2 million and an adjusted loss of $0.26 per share, outperforming consensus estimates. Spire also declared a quarterly …
SR
main company
Sharemaestro market context
Price below Trend Line
52 weeks +10.7% · Next-week setup positive 60.8%
Inspire Medical Systems, Inc. (NYSE:INSP) Given Consensus Recommendation of "Hold" by Analysts
Analysts have issued a consensus "Hold" rating for Inspire Medical Systems, Inc. (NYSE:INSP), with an average 12-month price target of $68.00. The company recently reported quarterly EPS of $0.14, surpassing expectations, and revenue of $200.6 million, although revenue declined 7.6% year over year. Institutional …
INSP
main company
Sharemaestro market context
Price above Trend Line
52 weeks -40.5%
Inspire medical systems chief mfg. officer Kelly sells $57,346 in stock
Jason P. Kelly, Chief Manufacturing and Quality Officer at Inspire Medical Systems (NASDAQ:INSP), sold 963 shares of company stock for a total of $57,346. Following the sale, Mr. Kelly directly owns 18,985 shares. Despite the stock being down 36% year-to-date, InvestingPro analysis suggests the …
INSP
main company
Sharemaestro market context
Price above Trend Line
52 weeks -40.5%
Inspire Medical Systems (NYSE:INSP) Insider Jason Kelly Sells 963 Shares of Stock
Inspire Medical Systems insider Jason Kelly sold 963 shares of the company's stock for approximately $57,346.65, reducing his holdings by 4.83%. The company recently reported better-than-expected quarterly earnings and revenue, but revenue was down 7.6% year-over-year. Analysts maintain a "Hold" rating on the stock …
INSP
main company
Sharemaestro market context
Price above Trend Line
52 weeks -40.5%
Inspire Medical Systems (INSP) Q2 2026 Earnings Call Transcript
Inspire Medical Systems (INSP) reported Q2 2026 revenue of $200.6 million, a 7.6% decrease due to coding and reimbursement disruptions, but raised its full-year revenue guidance to $835 million to $875 million. The company launched "Project Horizon" to optimize its organizational structure and supply …
INSP
main company
Sharemaestro market context
Price above Trend Line
52 weeks -40.5%
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin
Aspire Biopharma Holdings, Inc. announced its successful participation in CPHI Frankfurt, engaging in strategic discussions with global pharmaceutical companies regarding its sublingual high-dose aspirin. The company conducted numerous meetings with major industry players to explore technical collaboration and licensing opportunities for its lead product …
ASBP
main company
Sharemaestro market context
Price below Trend Line
52 weeks -98.8% · Next-week setup negative 44.9%
Price to sales ratio of Inspire Medical Systems, Inc. – HAM:2DR
This article focuses on the price to sales ratio of Inspire Medical Systems, Inc. (HAM:2DR) on the Hamburg Stock Exchange. It provides general financial overview information for the company as listed on TradingView.
INSP
main company
Sharemaestro market context
Price above Trend Line
52 weeks -40.5%
5 Insightful Analyst Questions From Inspire Medical Systems’s Q2 Earnings Call
Inspire Medical Systems (INSP) surpassed Q2 analyst expectations with improved operating income and positive cash flow, driven by better coding clarity and cost discipline. Management raised its full-year revenue and Adjusted EPS guidance, demonstrating resilience despite a year-on-year revenue decline. Analyst questions focused on …
INSP
main company
Sharemaestro market context
Price above Trend Line
52 weeks -40.5%
InspireMD Q2 Results: Second Quarter 2026 Earnings Release Date Set
InspireMD, Inc. will release its second quarter 2026 financial results on August 17, 2026, followed by a conference call and webcast at 8:30 a.m. ET. The company, known for its CGuard Prime carotid stent system, will discuss its financial performance and operational updates, including …
NSPR
main company
Sharemaestro market context
Price below Trend Line
52 weeks -58.6% · Next-week setup negative 42.7%
InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results
InspireMD (Nasdaq: NSPR) announced it will release its second quarter 2026 financial results on Monday, August 17, 2026. The company will host a conference call and live audio webcast at 8:30 a.m. Eastern Time to discuss the results and recent highlights. Investors can participate …
NSPR
main company
Sharemaestro market context
Price below Trend Line
52 weeks -58.6% · Next-week setup negative 42.7%
Inspire Medical Systems (INSP) Is Up 19.8% After Q2 Profit And Higher 2026 Guidance - Has The Bull Case Changed?
Inspire Medical Systems reported a swing to profit in Q2 2026 and raised its full-year 2026 revenue guidance, leading to a 19.8% stock increase. Despite this, the company faces ongoing challenges with the Inspire V rollout, marketing spend, and reimbursement policies. The article questions …
INSP
main company
Sharemaestro market context
Price above Trend Line
52 weeks -40.5%